Description

The Hepatic Fibrosis Test YRA317 // YRA321 represents a cutting-edge solution in the early detection and management of liver fibrosis. Early intervention is crucial, as hepatic fibrosis can be completely reversed at its initial stages, significantly improving the patient’s quality of life and prognosis. Compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, this test ensures advanced accuracy in detecting key parameters of liver health.

Market Price

The price range for the Hepatic Fibrosis Test YRA317 // YRA321 typically varies based on supplier and bulk purchase agreements. On average, prices can range between $500 to $1000 per box of tests. For precise pricing and special offers, we recommend generating a quote through our Kalstein Plus platform.

Frequently Asked Questions

Q: How is the Hepatic Fibrosis Test YRA317 // YRA321 stored?

A: It should be stored at temperatures between 2-8°C to ensure test accuracy and longevity.

Q: What methods does the test use for analysis?

A: The analysis is based on the CLIA (Chemiluminescence Immunoassay) method for precise and reliable results.

Advantages and Disadvantages

The main advantage of using the Hepatic Fibrosis Test YRA317 // YRA321 is its potential to facilitate early intervention, which can arrest or even reverse liver damage. This can dramatically alter patient outcomes by delaying or preventing progression to cirrhosis. A potential disadvantage is the need for specific analyzers (YR06389 and YR06390), which may require additional investment if not already available in your facility.

Product Use in the Field

In practical scenarios, the Hepatic Fibrosis Test YRA317 // YRA321 is used by medical professionals to monitor liver fibrosis progression and evaluate the effectiveness of therapeutic interventions. It is an invaluable tool in both research and clinical settings.

Recommendations

For optimal performance of the Hepatic Fibrosis Test YRA317 // YRA321, ensure strict adherence to storage guidelines and analyzer compatibility. Regular calibration as specified will uphold the accuracy of results, thereby maximizing the test’s potential benefits. Consider enrolling in maintenance programs to ensure analyzer performance.

Features

• Compatibility with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390.
• Uses CLIA methodology for precise results.
• Detects key indicators of liver fibrosis, offering early intervention opportunities.
• CE, ISO13485, and FSC certified.

Technical Specifications